Skip to main content

Smith & Nephew (SN) Receives a Buy from Goldman Sachs

Tipranks - Fri Mar 6, 12:38AM CST

Goldman Sachs analyst Richard Felton reiterated a Buy rating on Smith & Nephew yesterday and set a price target of p1,700.00. The company’s shares closed yesterday at p1,336.00.

Claim 70% Off TipRanks Premium

According to TipRanks, Felton is a 3-star analyst with an average return of 4.7% and a 55.46% success rate. Felton covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, Fresenius SE & Co. KGaA, and GN Store Nord.

In addition to Goldman Sachs, Smith & Nephew also received a Buy from Bank of America Securities’s Julien Ouaddour in a report issued yesterday. However, on the same day, TipRanks – xAI reiterated a Hold rating on Smith & Nephew (LSE: SN).

Based on Smith & Nephew’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of p3.31 billion and a net profit of p342.47 million. In comparison, last year the company earned a revenue of p2.98 billion and had a net profit of p198 million

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.